Nobel Laureate Prof Morten Meldal, currently on India visit, called on Union Minister of State (Independent Charge) Science & Technology; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh here today and discussed bilateral collaboration in pharmaceuticals and promotion of Chemistry studies among school children.
Hailing from Denmark, which is the home to one of the world’s biggest Insulin producing houses called Novo Nordisk, the Nobel Laureate spent considerable time discussing Insulin and Diabetes management with Dr Jitendra Singh who also happens to be a nationally known Diabetologist.
Awarded jointly the 2022 Nobel Prize in Chemistry for the groundbreaking development of ‘Click chemistry and bioorthogonal chemistry’, Prof Meldal, who is a Professor in the University of Copenhagen, was accompanied by his wife Phaedria Marie Hilaire, who is an acclaimed Life Science Business Leader, DEIB Advocate and Angel Investor.
Pointing out that Denmark has a vibrant Biotechnology and pharmaceutical industry and some of the finest world class laboratories, Prof Meldal evinced keen interest in R&D, academia and business tie ups during his visit to India.
Denmark is home to major international pharmaceutical companies such as Novo Nordisk, Lundbeck, LEO Pharma and ALK. Novo Nordisk, alone, holds a 50% share of the global Insulin market.
Prof Meldal said Denmark’s biotech and pharma cluster has a global reputation for cutting-edge research, particularly in cancer, the central nervous system (CNS), diabetes care and within inflammatory and infectious diseases. The Nordic nation has one of the strongest clusters in the world when it comes to biotech and life science, based on robust public-private partnerships.
Prof Meldal, who delivered lectures at the CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), IIT Delhi and Miranda House in the city, said he was very impressed with the work done at the Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Enterprise set up by Department of Biotechnology (DBT).
Welcoming Prof Meldal’s interest in India’s BT and Pharma Industry, Dr Jitendra Singh said the two countries can engage in any sector in Sciences and proposed a long term plan that could be worked out.
Prof Meldal said experiments are on in Denmark to find an antibacterial and antiviral drug to treat Tuberculosis (TB).
Referring to Prime Minister Narendra Modi’s 5-pronged strategy to curb TB consisting of Trace, Test, Track, Treat and use Technology to eliminate tuberculosis from the country, Dr Jitendra Singh there is scope for collaboration in India’s National TB Elimination Programme (NTP).
Prof Meldal and Ms. St. Hilaire said they are very keen to start a programme to create awareness about Chemistry in young minds, children between ages 5-15, with an idea to “catch them young.”
Pointing out that CSIR has Mentorship and INSPIRE Fellowship programmes so that students could realise their aptitude, the S&T Minister said bilateral students and researcher exchange programmes can be worked out in detail.
Dr Jitendra Singh said, India is also looking for technology in renewable energy as the country aims for Net Zero emission targets by 2070.
Prof Meldal said Denmark is home to world-class companies in several industries, with a particular focus on renewable energy. More than 40 years of ambitious energy policies have helped put Denmark in the forefront of “cleantech”, and the country has a goal of being completely independent of fossil fuels by 2050.
 Science & Technology; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh){kind=link}